Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sonoma Pharmaceuticals (SNOA) Gross Profit (2020 - 2022)

Sonoma Pharmaceuticals (SNOA) has 3 years of Gross Profit data on record, last reported at $2.5 million in Q4 2012.

  • For Q4 2012, Gross Profit rose 33.42% year-over-year to $2.5 million; the TTM value through Dec 2012 reached $10.7 million, up 25.63%, while the annual FY2012 figure was $8.7 million, 41.9% up from the prior year.
  • Gross Profit reached $2.5 million in Q4 2012 per SNOA's latest filing, down from $3.2 million in the prior quarter.
  • Across five years, Gross Profit topped out at $3.2 million in Q3 2012 and bottomed at $1.1 million in Q4 2010.
  • Average Gross Profit over 3 years is $2.1 million, with a median of $1.9 million recorded in 2011.
  • Peak YoY movement for Gross Profit: skyrocketed 66.05% in 2011, then rose 10.62% in 2012.
  • A 3-year view of Gross Profit shows it stood at $1.1 million in 2010, then skyrocketed by 61.18% to $1.9 million in 2011, then surged by 33.42% to $2.5 million in 2012.
  • Per Business Quant database, its latest 3 readings for Gross Profit were $2.5 million in Q4 2012, $3.2 million in Q3 2012, and $2.9 million in Q2 2012.